Company Profile
Vitarka Therapeutics Ltd
13291464•Private Limited With Share Capital
Get Full Access
25/03/2021
5 years
4
3
72110
very low risk
Company Overview
Registration, classification & business activity
Vitarka Therapeutics Ltd (13291464) is a private limited with share capital incorporated on 25/03/2021 (5 years old) and registered in sandwich, CT139FF. The company operates under SIC code 72110 - research and experimental development on biotechnology.
Financial Overview
£482.5K
£20.8K
£461.7K
£480.7K
Key Metrics
3
Employees
4
Directors
6
Shareholders
1
PSCs
Board of Directors
Innovate Grants
This company received a grant of £455000.0 for Rnaopore: Tumour Targeted Non-Viral Delivery For Rna Therapeutics. The project started on 01/04/2023 and ended on 30/09/2024.
This company received a grant of £50000.0 for Endo-Pore: Targeted Non-Viral Cytoplasmic Delivery Of Nucleic-Acid Therapies. The project started on 01/11/2022 and ended on 28/02/2023.
+1 more grants available
Risk Assessment
very low risk
International Score
Future Factor
excellent
Performance Rating